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INTRODUCTION
Multiple sclerosis (MS) is a chronic, neurodegenerative disorder characterized by immune activation and loss of myelin in the central nervous system (CNS). Among the many sensory abnormalities associated with MS, pain is common and often debilitating. Pain is experienced by one third to a half of the population with MS at some point during their disease course and a significant percentage are diagnosed with neuropathic pain (1, 2) . Current pharmacological approaches to alleviate this pain have been largely ineffective with low patient confidence in prevailing treatment approaches (3) . To investigate the pathophysiology of pain in MS, we employed a commonly used animal model, experimental autoimmune encephalomyelitis (EAE).
Neuropathic pain is thought to arise from increased excitability of neurons along the pain axis, comprising sensory neurons in the peripheral dorsal root and trigeminal ganglia and the integrative central processes of the spinal cord and the brain (4) (5) (6) . The role of the CNS as a modulator of pain in MS/EAE has been widely studied (7) . However, only a handful of studies to date has investigated the contribution of the peripheral branch of the somatosensory nervous system to pain pathophysiology in EAE and MS (8) (9) (10) (11) (12) (13) (14) .
In response to MS/EAE, the central projections of the DRG neuronal somata may sustain indirect injury through chronic neuroinflammatory processes occurring in the CNS. These injuries at the spinal terminal may evoke a retrograde stress response in the cell bodies of the DRG. When cells are subject to chronic stressors, such as prolonged inflammation and cytoskeletal disruption, they may undergo endoplasmic reticulum (ER) stress. The ER is an important organelle required for lipid biosynthesis, calcium ion (Ca 2+ ) storage and protein folding and processing (15) . Stress can impair protein folding thus triggering a cascade of events that are collectively known as the unfolded protein response (UPR) (16, 17) .
The ER-based signalling mechanism initially functions to mitigate cellular damage.
Activation of the UPR is mediated by three ER stress sensor proteins, IRE1, PERK, and ATF6 (15) . Signaling initiated through these three independent pathways promotes cell survival by ultimately reducing misfolded protein levels both via reducing mRNA translation and via enhancing the ER's folding capacity. If the stressor is particularly severe or prolonged however, the UPR can drive the cell into an apoptotic program of regulated cell death (15, 17) . Emerging evidence is now demonstrating that ER stress may also be a significant factor for developing pain hypersensitivity in various animal models across a variety of cell types (18) (19) (20) (21) (22) (23) (24) (25) . In this study, we investigated whether ER stress in DRG neurons contributes to the well characterised pain hypersensitivity that occurs in the EAE model and by extension in MS (7, 26) .
MATERIALS AND METHODS

Human Tissue
Human tissue was obtained from the Netherlands Brain Bank (NBB; http://www.brainbank.nl).
Subjects or their next of kin provided written informed consent for the use of their tissue and clinical information for research purposes to the NBB. All MS individuals (n=9) experienced the progressive phase of the disease and presented evidence of chronic pain such as trigeminal neuralgia, migraine, extremity pain, and back pain. The average disease duration was 21.0±4.61 years. Average age at death was 78.6±4.32 years for the non-demented controls (n=7) and 59 .7±4.04 years for individuals with MS. The majority of the donors elected to be euthanized with a combination of barbiturates (thiopental, pentobarbital) and muscle relaxant (Rocuronium bromide). Only female human tissue was examined. Patient demographics are further summarized in Table 1 
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Snap frozen human DRGs were sectioned onto superfrost plus glass slides (VWR International, Leuven, Belgium) at 10µm thickness. Ten 10µm thick sections were harvested for RNA and protein analysis. Tissue was lysed in 600µl of Buffer RLT (Qiagen, 79216) with β mercaptoethanol (Sigma, M3148, 10µl/ml of Buffer RLT) using a 2 ml Potter-Elvehjem homogenizer. The homogenate was then centrifuged at full speed for 2 min in QIAshredder column (Qiagen, 79656). RNA was extracted from the flow-through using the RNeasy Mini Kit (Qiagen, 74104) according to manufacturer's instructions. RNA was quantified using a Nanodrop 2000. Reverse transcription and PCR analysis was performed as described later.
The flow-through after RNeasy spin column centrifugation step was stored at 4°C for protein extraction. The protein was precipitated using ice-cold acetone (500µl sample + 1500µl acetone). The acetone laden sample was store at -20°C for 2 hours and then centrifuged at 15,000g for 10 min at 4°C. The supernatant was discarded and the pellet was redissolved in 100µl of 5% SDS. Protein was quantified using the DC Protein Assay (BioRad, 5000112).
Western blots using 10µg of protein were performed as described below.
Immunohistochemical analysis of human DRG sections were performed similar to previously described (10, 27) . In brief, slides were fixed in acetone for 10 min, followed by three The use of tissue and access to medical records was approved from the Ethics Committee of the VU University Medical Center, Amsterdam, The Netherlands.
EAE induction and behavioural assessment
As previously described (9) Mechanical hypersensitivity, facial sensitivity, and gross locomotor ability were assessed as previously described (8, 9, 28) . Data was compared to the baseline threshold of each individual mouse in order to control for individual differences and experimenter variability.
4-PBA administration in vivo
4-PBA (200mg/kg; Tocris, 2682) was completely dissolved in 1X sterile PBS and injected intraperitoneally (n=6) daily, beginning at disease onset until day 7-10 post-onset. PBS was administered as a vehicle control (n=5). Von Frey testing was performed one-hour after injection on the day of disease onset. Facial sensitivity was assessed using the air puff assay one-hour after the final injection 7-10 days post onset.
Immunohistochemistry
The mouse tissue was fixed with 4% paraformaldehyde (PFA) in 0.1M phosphate buffer (PB) overnight at 4°C followed by two 30% sucrose washes, each overnight at 4°C. After removing excess sucrose, the tissue was embedded in Tissue-Tek OCT (Sakura Finetek, 4583). DRGs were cryosectioned with 10µm thickness while the spinal cords were sectioned at 20µm onto glass slides. The remaining staining protocol was identical to a previously established protocol (10) .
Western blotting
Protein lysates were diluted in RIPA (25mM Tris, 150mM NaCl, 0.1% SDS, 0.5% Na deoxycholate, 1% NP-40) with protease (cOmplete EDTA-free, Roche, 04693159001) and phosphatase inhibitors (PhosSTOP, Roche, 04906837001) and 5X sample buffer was added.
Directly before loading onto 10% SDS-PAGE gels, samples were boiled at 100°C for 10 min.
Gels were run at 150 V for 60 min and transferred onto nitrocellulose membranes with 400 mA over 120 min.
Membranes were stained with REVERT Total Protein Stain (Licor) according to manufacturer's instructions and then blocked in 2% BSA in 1X DPBS for 1 hour at room temperature followed by overnight incubation at 4°C with a primary antibody dissolved in blocking solution. Membranes were then washed 3 times (3 minutes each) in TBS-T and incubated in 2% milk in TBS-T with Alexa Fluor coupled secondary antibodies for 1 h at room temperature. After another wash step, membranes were scanned using an Odyssey infrared imager (Licor).
Western blots using human tissue were performed as previously described (10 
Quantitative real-time PCR
Reverse transcription and PCR analyses were performed as previously described (10) . Reverse transcription on human samples was performed using 160ng of total RNA. PCRs were performed on StepOne Plus thermocycler using Rpl5 (mouse) or RPLP0 (human) as housekeeping genes.
Primers used in this study were obtained from Qiagen: Rpl5 (PPM25102A), Xbp1 targeting multiple regions of the mRNA. The siRNA cocktail was prepared according to manufacturer's instructions. The final total siRNA concentration was 0.04µM (4 individual siRNAs, each at 0.01µM). 100µl of siRNA mixture was added to cells (100µl droplet) one hour after plating them onto glass coverslips. The cells were incubated for 10 min at 37°C and then topped up to 1 ml in cell media followed by incubation for 20-24 hours prior to Ca 2+ imaging.
Dissociated DRG cultures
Live cell Ca 2+ imaging in DRG neurons
Confocal imaging of cytosolic Ca 2+ transients was performed as previously described (11) 
Experimental Design and Statistical Analysis
Statistical analyses were performed using GraphPad Prism 6 with appropriate statistical tests.
Detailed statistical analyses have been mentioned in the Results section. Animals were assigned to each experimental group randomly. Western blot and PCR data were log-transformed prior to statistical testing in order to ensure the data fit the homogeneity of variance assumptions for each statistical test. The data presented in the figures is back-transformed onto a linear scale for the ease of the reader. Statistical annotations represent output of tests performed on log-transformed data. Significance was set at p<0.05. Graphics were generated using Biorender.com.
Data availability
The data that support the findings of this study are available from the corresponding author, upon reasonable request.
RESULTS
Inflammation and ER stress in the post-mortem MS DRG
Although MS is classically identified as a CNS targeted disease, we sought to investigate whether sensory neurons residing in the DRG of the PNS are also affected by the disease. We first examined post-mortem DRG tissue from MS patients for activation of innate and adaptive immune responses. At the transcript level, the complement component 3a receptor 1 (C3AR1), and complement component 5a receptor 1 (C5AR1), were upregulated in MS tissue compared to non-demented controls (t C3aR1 (10)=2.019, p=0.0711; t C5aR1 (11)=3.928, p=0.0024, unpaired t-test) ( Fig. 1A, B ). We also noted a significant increase in the T-cell marker transcripts, CD3 and CD4, further suggesting that the adaptive immune response was engaged in the DRG during the disease (t CD3E (11)=4.358, p=0.0011; t CD4 (11)=3.466, p=0.0053, unpaired t-test) (Fig. 1C , D).
Similar activation at the level of the DRG in the EAE animal model has been previously described by our group (10) . Further analysis revealed a significant increase in specific markers of ER stress at the level of the DRG in MS. XPB1 mRNA as well as BiP and XBP1 protein levels were increased in MS tissue suggesting that the DRG in MS undergoes ER stress (PCR: We next performed immunofluorescence experiments to identify the source of inflammation and ER stress. C5aR1 (CD88), and CD3 immunopositive immune cells were increased in MS samples as compared to non-demented controls (Fig. 1I ). Furthermore, BiP expression was observed to be increased in MS DRGs and largely localized to sensory neurons ( Fig. 1I ). This data indicates that peripheral sensory neurons in the DRG of MS patients are subjected to immune activation and ER stress. 
EAE mice develop pain hypersensitivity
We next generated EAE in female C57BL/6 mice using myelin oligodendrocyte glycoprotein (MOG ). The median day for the onset of EAE clinical signs was day 10 post immunization ( Fig. 2A, B 2D ).
Hence, mechanical hypersensitivity observed in EAE mice at disease onset was not confounded by paralysis or lack of motor coordination. 
ER stress in the DRG of EAE mice
We next assessed the expression of ER proteins in the DRG of mice with EAE over the course of the disease. The levels of BiP, a luminal ER chaperone, were elevated in the DRG at the chronic stage of the disease (F BiP (2, 9) =7.950, p=0.0103, One-way ANOVA) ( Fig. 2E ). Levels of phosphorylated eIF2α (p-eIF2α) were significantly upregulated at the chronic time point whereas total eIF2α (t-eIF2α) levels only trended toward an increase with the progression of disease (F t-eIF2α (2, 9) =3.808, p=0.0633, F p-eIF2α (2, 9) =7.030, p=0.0145; One-way ANOVA) ( Fig.   2F , G). Hence, phosphorylation of eIF2α, as measured by the ratio of p-eIF2α to t-eIF2α, was found to be increased at the chronic timepoint (F p-eIF2α/t-eIF2α (2, 9) =12.75, p=0.0024; One-way ANOVA) ( Fig. 2H) . Interestingly, levels of the UPR transcription factors XBP1 and CHOP were upregulated at disease onset and remained elevated into the chronic phase (F XBP1 (2, 9) =18.59, p=0.0006; F CHOP (2, 9) =12.08, p=0.0028, One-way ANOVA) ( Fig. 2I, J) .
A key feature of the UPR involves IRE1α splicing of XBP1 mRNA to generate a spliced isoform of XBP1 which acts as a potent transcription factor (16, 29) . To further elucidate the cellular origin of XBP1, we performed an IHC experiment and discovered that the proportion of neurons with nuclear staining of XBP1 (nXBP1) was increased significantly in the DRG of mice with EAE (F total cells (2,12)=9.910, p=0.0029, One-way ANOVA) ( Fig. 2L, M) . On closer inspection, smaller (<30µm) diameter neurons demonstrated a significant increase in nXBP1 expression with EAE while larger (≥ 30µm) diameter cells showed minimal change in nXBP1 levels. (F <30um (2,12)=12.12, p=0.0013; F ≥ 30um (2,12)=0.3210, p=0.7314, One-way ANOVA) ( Fig.   2N, O) . These results suggest that the ER stress-pertinent spliced isoform of XBP1 is upregulated in small diameter, putative nociceptors in the DRG.
4-PBA treatment alleviates mechanical and facial hypersensitivity
Recently, the chemical chaperone, 4-phenylbutyric acid (4-PBA), has been shown to ameliorate neuropathic pain by reducing ER stress (18, 22, 30) . We wanted to investigate if daily systemic treatment with 4-PBA (200 mg/kg) starting at the onset of disease (Fig. 3A) would alter EAE disease course and relieve mechanical and orofacial hypersensitivity in mice with EAE. DRGs were then harvested after 7-10 days of treatment with either 4-PBA or vehicle (1x PBS). We did not observe any change in disease course following 4-PBA treatment (F(10,183)=0.2834, p=0.9842) ( Fig. 3B) . At the onset of clinical signs and before 4-PBA administration, we observed the characteristic reduction in von Frey thresholds in mice with EAE. One-hour after 4- (Fig. 3C ). Due to the ensuing paralysis of the hind limbs at later stages in the disease, we could not assess hindpaw mechanical hypersensitivity 7-10 days post onset at the time of tissue harvest. Instead, we analysed orofacial pain behaviours (headshakes, single swipe, and continuous swipes) using an air puff assay (8) . As compared to vehicle treated animals, daily 4-PBA treatment dampened total facial pain behaviours by 50%, headshakes by 66%, single swipe by 50%, and continuous swipes by 33% ( Fig. 3D) . 
4-PBA treatment does not alter inflammation and ER stress in the spinal dorsal
horn CNS inflammation has been linked to pain hypersensitivity in EAE mice (26) . To assess whether the antinociceptive effects of 4-PBA were mediated by altered inflammatory responses in the superficial dorsal horn of the spinal cord (SDH), we quantified the levels of Iba1+ microglia/macrophages and CD4+ T-cells in this region (Fig. 4A, B ). The levels of Iba1 and CD4 immunoreactivity were elevated in the SDH of both vehicle and 4-PBA treated animals and were not significantly different between treatments (F Iba1 (2,11)=17.38, p=0.0004; F CD4 (2,11)=32.88, p<0.0001, one-way ANOVA). Interestingly, XBP1 immunoreactivity was also increased in the SDH with disease but its expression was not affected with 4-PBA treatment (F XBP1 (2,11)=7.845, p=0.0076, one-way ANOVA) ( Fig. 4C ). cFOS, a commonly used marker of cellular activity, was elevated in the SDH of EAE animals as shown previously (31) . cFOS expression in the SDH of 4-PBA administered animals was however, normalized (F cFOS (2,12)=3.998, p=0.0467, one-way ANOVA) ( Fig. 4D ). Collectively, these results suggest that 4-PBA's antinociceptive effects were not due to a change in immune activation or infiltration in the SDH nor can it be accounted for by a reduction in ER stress in this region.
Instead, the normalized levels of cFOS with 4-PBA treatment suggest a possible reduction in peripheral afferent drive into the spinal dorsal horn. 
4-PBA treatment reduces ER stress in the DRG
To further investigate the mechanism of 4-PBA's beneficial effects on pain behaviours in EAE, levels of UPR-related proteins in the DRG were assessed after 4-PBA treatment (Fig. 5 ). The levels of the ER stress proteins, BiP and t-eIF2α, remained unchanged with 4-PBA treatment (t BiP (8)=0.4978, p=0.6320; t t-eIF2α (8)=1.110, p=0.1495; unpaired t-test) (Fig. 5A, B) . However, we observed significant reductions in the phosphorylation of eIF2α, XBP1, and CHOP levels in 
4-PBA dampens Ca 2+ responses in small diameter neurons
4-PBA, or its salt sodium 4-phenylbutyrate, can alleviate ER stress primarily as a chemical chaperone (32) (Fig. 6A ). To further investigate the impact of 4-PBA on neuronal function, we imaged cytosolic Ca 2+ transients in dissociated DRG neurons from EAE animals upon caffeine (20mM) and KCl (30mM) stimulation (Fig. 6B ). Caffeine is known to sensitize ryanodine receptors to cytosolic Ca 2+ leading to a Ca 2+ -induced calcium release (CICR) from the ER. t-test) ( Fig. 6-1) . These results suggest that 4-PBA reduces CICR and KCl mediated excitability in small diameter cells of the DRG from EAE mice by dampening ER stress. 
Knockdown of Ddit3 and Xbp1 mRNA does not alter evoked Ca 2+ rises
Earlier, we observed a reduction in CHOP and XBP1 in vivo after treatment with 4-PBA. To ascertain the contribution of these transcription factors to enhanced Ca 2+ signalling observed in EAE cells ( Fig. 6; Mifflin et al., 2019) , we silenced gene expression of CHOP (encoded by Ddit3) and Xbp1 in dissociated DRG neurons from EAE animals (Fig. 7A) (2, 12) =5.020, p=0.0260, one-way ANOVA) ( Fig. 7G-I) . Moreover, in order to further assess the efficacy of the transfection system, we transfected dissociated neurons with Alexa
Fluor 488-conjugated nonsilencing siRNA which has no known homology to any mammalian gene (Fig. 7J) . The presence of this siRNA in our neurons suggested that our experimental siRNAs were indeed being delivered into the neurons. Altogether, these data indicate that a selective reduction in either CHOP or XBP1 is not sufficient to reduce CICR or KCl excitability in dissociated DRG neurons from EAE animals. We observed that BiP (Hspa5) expression was also reduced upon knockdown of XBP1 and CHOP mRNA. (J) To further validate our siRNA delivery system, we transfected cells with a negative siRNA tagged with Alexa Fluor 488. We found that dissociated neurons were transfected with (-)-siRNA using our delivery system further suggesting that XBP1 and CHOP siRNA were successfully delivered in our primary neurons. ### p<0.001; ****, #### p<0.0001, one-way ANOVAs with Tukey's post-hoc analysis.
The PERK inhibitor, AMG44, reduces Ca 2+ signalling in small diameter neurons
Upon ER stress, PERK autophosphorylates, oligomerizes, and subsequently phosphorylates eIF2α (16) .Western blotting of DRGs obtained from EAE mice at disease onset show increased phosphorylation of PERK (t(7)=4.554, p=0.0026, unpaired t-test) (Fig. 8A) . To investigate the contribution of ER stress-mediated and PERK induced eIF2α activation, we treated DRG cells from EAE animals with a novel PERK inhibitor, AMG PERK 44 (AMG44) (33) (Fig. 8B) 6-1 ) suggesting that intervening with the PERK arm of UPR allows for a shift towards a more protective IRE1-XBP1-BiP branch of the UPR. 
BK channel current is rescued by 4-PBA and AMG44 treatment
In a previous study (10) , we noted a reduction in the afterhyperpolarization amplitude of small diameter, putative nociceptive neurons from mice with EAE. Ca 2+ is known to alter the function of Ca 2+ -sensitive K + channels and hence, we asked whether BK channel properties are modified with EAE disease considering the altered Ca 2+ dynamics we observed earlier. In order to prevent dialysing intracellular calcium, we performed amphotericin B perforated patch clamp recordings.
We found paxilline-sensitive BK channel current almost exclusively in small diameter IB4+ neurons similar to previous reports (Fig. 9A, D) (34) . We also found that the conductancevoltage (GV) curve was right-shifted in IB4+ EAE neurons as compared to neurons from CFA animals suggesting that BK channel activity was modified in EAE ( Fig. 9B, E ). 4-PBA and AMG44 treatment normalized the GV relationship of the BK channels (Fig. 9C, F) . EAE responses (red) are the same in Fig. 9B and C. In effect, 0 mV test voltage (red trace) minimally activated paxilline-sensitive BK currents in EAE neurons compared to other conditions illustrating the strong shift in voltage-dependent gating of BK channels in EAE neurons (red trace; Fig. 9E, F) . The conductance-voltage relationship was quantified as the voltage required for half the maximum conductance (i.e. V 1/2 ) across the cell membrane ( with Welch's correction) ( Fig. 10A) . Similarly, DRGs from EAE animals also showed a loss of Kcnmb4 transcripts (t KCNMB4 (6.985)=3.034, p=0.0191, unpaired t-test with Welch's correction) ( Fig. 10B) . In vitro, 4-PBA and AMG44 treatment increased Kcnmb4 expression in EAE neurons (t 4-PBA (6)=2.731, p=0.0341; t AMG44 (8)=2.689, p=0.0275, unpaired t-test) (Fig. 10C, D) . Likewise, the expression of β 1 subunit transcripts (Kcnmb1) was reduced in whole DRGs obtained from EAE animals and the loss of Kcnmb1 expression was rectified with 4-PBA and AMG44 treatment in vitro (t MS (11)=0.7320, p=0.4795; t EAE (9)=3.784, p=0.0043; t 4-PBA (6)=3.132, p=0.0203; t AMG44 (8)=2.574, p=0.0329, unpaired t-test) ( Fig. 10-1) . These data suggest that disease-induced ER stress alters BK channel functioning by modulating auxiliary subunits, particularly the β 4 subunit, in IB4+ sensory neurons. 
DISCUSSION
Our results show for the first time that post-mortem DRGs from MS patients show evidence of inflammation and immune activation as well as increased expression of ER stress markers. These observations demonstrate that MS pathology extends beyond the CNS into the PNS. Several recent reports have implicated ER stress in mediating pain hypersensitivity in various models of neuropathy, including diabetic neuropathy (18, 20, 36) , spinal nerve ligation (24, 37) , vasculitic peripheral neuropathy (22) and CFA-induced orofacial neuropathy (38) .
Although MS, like many other neurodegenerative disorders, has previously been associated with ER stress (15, 16, 39) , prior reports have largely focused on studying ER stress and the integrated stress response (ISR) in oligodendrocytes in EAE in the context of CNS demyelination (40) (41) (42) . In contrast, our study highlights a novel role of ER stress in sensory neurons of the PNS for mediating pain in MS/EAE. Application of 4-PBA has been shown to improve metabolic syndromes, congenital and genetic protein misfolding disorders, inflammation, and neurological disorders such as Parkinson's disease and ischemic brain injury (43) . Daily administration of 4-PBA in our study ameliorated acute mechanical hypersensitivity as well as chronic facial pain behaviours without altering the clinical signs of the disease (Fig. 3) . A previous study using 4-PBA in EAE, observed that treatment with 4-PBA (400 mg/kg/day) at the time of disease induction reduced clinical signs of EAE (44) . Our current study employs a different variant of the EAE model.
Additionally, we designed our study with 4-PBA administration beginning at the onset of clinical signs of EAE to limit the effects of reduced disease severity and its impact on pain behaviours.
We were interested in investigating the role of ER stress on pain hypersensitivity in EAE rather than the effect of 4-PBA on the disease itself. Evidently, once EAE has been initiated, 4-PBA administration does not alter EAE disease course or immune activation in the dorsal spinal cord ( Fig. 3, 4 ). In the DRG, however, 4-PBA broadly reduced levels of ER stress related proteins ( Fig. 5) .
The ISR has previously been implicated in pain pathophysiology (19, 36) as well as EAE (45, 46) . The ISR pathway involves the phosphorylation of eIF2α by an assortment of kinases -PERK, protein kinase R (PKR), heme-regulated eIF2α kinase (HRI), and general control nonderepressible 2 kinase (GCN2) -each of which is initiated by a variety of stressors (47, 48) .
Phosphorylation of eIF2α allows the cell to rapidly respond to a stressor by reducing translation of certain genes and increasing translation of others, especially genes with upstream open reading frame (uORF) including, but not limited to, ATF4 and CHOP. Selective translation of genes that may enhance the excitability of sensory neurons in the context of pain, particularly IB4+ nociceptors, has recently been reported (36) . ISR inhibitor (ISRIB) is a commonly used compound to suppress the effects of p-eIF2α without altering its levels (49) however the initiating stressors (e.g. UPR, viral infection, amino acid deprivation etc.) and associated kinase activation remain ambiguous. In this study, we hoped to isolate the functional effects of UPRmediated PERK signalling using a recently developed inhibitor of PERK phosphorylation, AMG44 (33) . We found that AMG44 in vitro could suppress caffeine stimulated CICR and KCl mediated Ca 2+ excitability in small diameter cells while gene knock-down of CHOP and XBP1 had no effect on Ca 2+ responses of sensory neurons (Fig. 7, 8 ). AMG44 also normalized BK channel physiology in dissociated DRGs from EAE mice as well as mRNA levels of the β 4 and β 1 auxiliary subunits of BK channels ( Fig. 9, 10 (53) . To this effect, a reduction in BK channel current in the DRG is also associated with nerve injury (54, 55) and inflammation-induced pain (56) (57) (58) . In this study, we found paxilline-sensitive BK channel currents almost exclusively in IB4+ sensory neurons ( Fig. 9) similar to what has previously been reported (34) . BK channels may be spatially coupled to voltage-gated Ca 2+ channels and ryanodine receptors allowing even small increases in cytosolic Ca 2+ to immediately influence the excitability of the cell (59, 60) . Moreover, reduced BK channel activity, as observed in this study, has been implicated in increased neurotransmission (53, 61) , hyperexcitability (34) and a more depolarized resting membrane potential (62) .
Behaviourally, sensory neuron specific (SNS) knockout of the pore-forming BK α subunit enhanced chronic inflammatory pain while a BK channel opener, NS1619, dampened inflammation-induced pain behaviours, suggesting that BK channels inhibit sensory input in inflammatory states (58) . In this regard, we observe a loss of BK α subunit mRNA expression in the DRG of EAE mice ( Fig. 10-1 ). However, 4-PBA and AMG44 treatment of EAE sensory neurons in vitro did not reverse this loss, implying that ER stress mechanisms may affect other modulatory subunits of BK channels in this disease.
The auxiliary subunits of BK channels modulate the channel's Ca 2+ and voltage sensitivity, ultimately modulating the cell's firing properties (53, 60) . In particular, the β 4
subunit slows activation and deactivation kinetics of the BK channel as well as reducing Ca 2+ sensitivity of the channel at low intracellular Ca 2+ levels while increasing Ca 2+ sensitivity at high intracellular Ca 2+ concentrations (63) . Knockout of the β 4 subunit in hippocampal dentate gyrus granule cells increased fast afterhyperpolarization amplitude and spike frequency of the cell (60) .
Loss of β 4 subunits is further correlated with seizure activity and heterozygous β 4 knockout mice are particularly prone to kainic acid induced seizures (64) . Of note, increased neuronal activity is also postulated to reduce levels of β 4 subunits in an activity-dependent manner (64) .
As such, we observed a loss of β 4 mRNA expression in the DRG of EAE mice, corresponding to a depolarizing shift in the V 1/2 of BK channels in IB4+ neurons and the onset of pain hypersensitivity in our model. In vitro, 4-PBA and AMG44 treatment on EAE neurons increased the expression of Kcnmb4 and normalized BK channel properties. Interestingly, β 4 mRNA was also reduced in the DRGs of MS patients further suggesting that BK channel physiology may be affected in MS. Hence, alleviation of ER stress may ameliorate pain in MS by normalizing BK channel physiology.
Current approaches to treat pain in MS generally involves NSAIDs, opioids, antidepressants, and antiepileptics. However, these treatment avenues often offer minimal relief and accompany a host of undesired side-effects (3, 65) . Since BK channels are ubiquitously expressed in a variety of tissues, including the circulatory system, pharmacologically targeting BK channels directly may also result in severe side-effects (66) . In contrast, ER stress modulators like 4-PBA and AMG44 can alleviate ER stress and normalize BK channel properties, ameliorating pain and limiting the chances for adverse side-effects ( Fig. 11A, B) . Figure 11 . Proposed mechanism (E, F) Sensory neurons, particularly IB4+ nociceptors, from EAE experience ER stress and consequent activation of the PERK-eIF2α pathway. Subsequent modulation of BK channel physiology and ER-Ca 2+ dyshomeostasis ultimately contributes to pain hypersensitivity in EAE mice. 4-PBA and AMG44 reduce ER stress and PERK phosphorylation, respectively, to normalize Ca 2+ homeostasis, BK channel physiology, and alleviate pain. 
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